Advertisement
Review Article| Volume 42, ISSUE 4, P699-712, December 2015

Emergency Contraception

Do Your Patients Have a Plan B?

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Raymond E.
        • Cleland K.
        Clinical practice. Emergency contraception.
        N Engl J Med. 2015; 372: 14
        • Trussell J.
        • Leveque J.
        • Koenig J.
        • et al.
        The economic value of contraception: a comparison of 15 methods.
        Am J Public Health. 1995; 85: 494-503
      1. Hatcher R. Trussell J. Nelson A.L. Contraceptive technology. 20th revised edition. Ardent Media, New York2011
        • Mosher W.D.
        • Jones J.
        Use of contraception in the United States: 1982-2008.
        Vital Health Stat 23. 2010; : 1-44
        • Grimes D.
        • Raymond E.
        • Jones B.
        Emergency contraception over-the-counter: the medical and legal imperatives.
        Obstet Gynecol. 2001; 98: 151-155
        • Raymond E.G.
        • Weaver M.A.
        Effect of an emergency contraceptive pill intervention on pregnancy risk behavior.
        Contraception. 2008; 77: 333-336
        • Weaver M.A.
        • Raymond E.G.
        • Baecher L.
        Attitude and behavior effects in a randomized trial of increased access to emergency contraception.
        Obstet Gynecol. 2009; 103: 107-116
        • Raine T.R.
        • Harper C.C.
        • Rocca C.H.
        • et al.
        Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and SITs: a randomized control trial.
        JAMA. 2005; 293: 54-62
        • Polis C.B.
        • Schaffer K.
        • Blanchard K.
        • et al.
        Advance provision of emergency contraception for pregnancy prevention (full review).
        Cochrane Database Syst Rev. 2007; (CD005497)
        • Glasier A.
        • Cameron S.
        • Blithe D.
        • et al.
        Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel.
        Contraception. 2011; 84: 363-367
        • Wilcox A.
        • Dunson D.
        • Weinberg C.
        • et al.
        Liklihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives.
        Contraception. 2001; 63: 211-215
        • Kapp N.
        • Abitbol J.L.
        • Mathe H.
        • et al.
        Effect of body weight and BMI on the efficacy of levonorgestrel contraception.
        Contraception. 2015; 91: 97-104
        • Raymond E.
        • Taylor D.
        • Trussell J.
        • et al.
        Minimum effectiveness of the levonorgestrel regimen of emergency contraception.
        Contraception. 2004; 69: 79-81
        • Cameron S.
        • Glasier A.
        The need to take a “new look” at emergency contraception.
        J Fam Plann Reprod Health Care. 2010; 36: 3-4
        • Wilcox A.
        • Weinberg C.
        • Baird D.
        Timing of sexual intercourse in relation to ovulation.
        N Engl J Med. 1995; 333: 1517-1521
        • Noe G.
        • Croxatto H.B.
        • Salvatierra A.M.
        • et al.
        Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation.
        Contraception. 2011; 84: 486-492
        • Li D.
        • Wilcox A.
        • Dunson D.
        Benchmark pregnancy rates and the assessment of post-coital contraceptives: an update.
        Contraception. 2015; 91: 344-349
      2. Westley E, Rich S, Lawton H. New research in emergency and postcoital contraception. Curr Obstet Gynecol Rep. Published online April 01, 2014. http://dx.doi.org/10.1007/s13669-014-0079-6. Accessed September 7, 2015.

        • Lundsberg L.
        • Pal L.
        • Gariepy A.
        • et al.
        Knowledge, attitudes, and practices regarding conception and fertility: a population-based survey among reproductive-age United States women.
        Fertil Steril. 2014; 101: 767-774
        • Raymond E.G.
        • Stewart F.
        • Weaver M.
        • et al.
        Impact of increased access to emergency contraceptive pills: a randomized controlled trial.
        Obstet Gynecol. 2006; 108: 1098-1106
        • Trussell J.
        • Guthrie K.
        Talking straight about emergency contraception.
        J Fam Plann Reprod Health Care. 2007; 33: 139-142
      3. Trussell J, Raymond E, Cleland K. Emergency contraception: a last chance to prevent unintended pregnancy. Available at: http://ec.princeton.edu/questions/ec-review.pdf. Accessed May 8, 2015.

        • Wu S.
        • Godfrey E.M.
        • Wojdyla D.
        • et al.
        Copper T380A intrauterine device for emergency contraception: a prospective, multicenter, cohort clinical trial.
        BJOG. 2010; 117: 1205-1210
        • Cheng L.
        • Che Y.
        • Gulmezoglu A.M.
        Interventions for emergency contraception.
        Cochrane Database Syst Rev. 2012; (CD001324)
        • Cleland K.
        • Zhu H.
        • Goldstuck N.
        • et al.
        The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience.
        Humanit Rep. 2012; 27: 1994-2000
        • Turok D.K.
        • Godfrey E.M.
        • Wojdyla D.
        • et al.
        Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
        Humanit Rep. 2013; 28: 2672-2676
        • Centers for Disease Control and Prevention
        US Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization Selected Practice Recommendations for Contraceptive Use, 2nd Edition.
        MMWR Recomm Rep. 2013; 62: 1-60
        • Zhou L.
        • Xiao B.
        Emergency contraception with multiload CU-375 SL IUD: a multicenter clinical trial.
        Contraception. 2001; 64: 107-112
        • Harper C.
        • Speidel J.
        • Drey E.
        • et al.
        Copper intrauterine device for contraception: clinical practice among contraceptive providers.
        Obstet Gynecol. 2012; 119: 220-226
        • Lalitkumar P.G.L.
        • Berger C.
        • Gemzell-Danielsson K.
        Emergency contraception.
        Best Pract Res Clin Endocrinol Metab. 2013; 27: 91-101
        • Gemzell-Danielsson K.
        • Berger C.
        • Lalitkumar P.G.L.
        Emergency contraception- mechanisms of action.
        Contraception. 2013; 87: 300-308
        • Stanford J.
        • Mikolajczyk R.
        Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects.
        Am J Obstet Gynecol. 2002; 187: 1699-1708
        • Roblero L.
        • Guadarrama A.
        • Lopez T.
        • et al.
        Effect of copper ion on the moltility, viability, acrosome reaction and fertilizing capacity of human spermatozoa in vitro.
        Reprod Fertil Dev. 1996; 8: 871-874
        • Ulmann G.
        • Hammerstein J.
        Inhibition of sperm motility in vitro by copper wire.
        Contraception. 1972; 6: 71-76
        • Kesseru E.
        • Camacho-Ortega P.
        Influence of metals on in vitro sperm migration in the human cervical mucus.
        Contraception. 1972; 6: 231-240
        • Hefnawi F.
        • Kandil O.
        • Askalani H.
        • et al.
        Influence of the copper IUD and the Lippes loop on sperm migration in the human cervical mucus.
        Contraception. 1975; 11: 541-547
        • Hagenfeldt K.
        • Johannisson E.
        • Brenner P.
        Intrauterine contraception with the copper-T device. Effect upon endometrial, morphology.
        Contraception. 1972; 6: 207-218
        • Larsson B.
        • Hamberger L.
        The concentration of copper in human uterine secretion during four years after insertion of a copper-containing intrauterine device.
        Fertil Steril. 1977; 28: 624-626
        • Wollen A.L.
        • Sandvei R.
        • Skare A.
        • et al.
        The localization and concentration of copper in the fallopian tube in women with or without an intrauterine contraceptive device.
        Acta Obstet Gynecol Scand. 1994; 73: 195-199
        • Larsson B.
        • Lijung B.
        • Hamberger L.
        The influence of copper on the in vitro motility of the human fallopian tube.
        Am J Obstet Gynecol. 1976; 125: 682-690
        • Ortiz M.
        • Croxatto H.
        Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action.
        Contraception. 2007; 75: S16-S30
        • National Collaborating Centre for Women’s Health
        Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception.
        RCOG Press, London2005
        • Centers for Disease Control and Prevention
        US Medical Eligibility Criteria for Contraceptive Use, 2010.
        MMWR Recomm Rep. 2010; 59: 50-51
      4. International Consortium for Emergency Contraception Policy Statement. The Intrauterine Device for Emergency Contraception. 2012. Available at: www.cecinof.org. Accessed March 27, 2015.

        • Mohllajee A.
        • Curtis K.
        • Peterson H.
        Does insertion and use of intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review.
        Contraception. 2006; 73: 145-153
        • Grimes D.
        Intrauterine device and upper-genital-tract infection.
        Lancet. 2000; 356: 1013-1019
        • Farley T.M.
        • Rosenberg M.J.
        • Rowe P.J.
        • et al.
        Intrauterine devices and pelvic inflammatory disease: an international perspective.
        Lancet. 1992; 339: 785-788
        • Brahmi D.
        • Steenland M.
        • Renner R.M.
        • et al.
        Pregnancy outcomes with an IUD in situ: a systematic review.
        Contraception. 2012; 85: 131-139
        • World Health Organization
        Mechanism of action, safety and efficacy of intrauterine devices. Report of a WHO Scientific Group.
        World Health Organ Tech Rep Ser. 1987; 753: 1-91
        • Blumenthal P.
        • Voedisch A.
        • Gemzell-Danielsson K.
        Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception.
        Hum Reprod Update. 2011; 17: 121-137
        • Creinin M.
        • Schlaff W.
        • Archer D.
        • et al.
        Progesterone receptor modulator for emergency contraception.
        Obstet Gynecol. 2006; 108: 1089-1097
        • Glasier A.
        • Cameron S.
        • Fine P.
        • et al.
        Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized non-inferiority trial and meta analysis.
        Lancet. 2010; 375: 555-562
      5. Trussell J, Cleland K. Emergency contraceptive pill efficacy and BMI/body weight. Contraceptive technology. Available at: http://www.contraceptivetechnology.org/latebreakers/emergency-contraceptive-pill-efficacy-bmibody-weight/. Accessed July 22, 2015.

        • Brach V.
        • Cochon L.
        • Jesam C.
        • et al.
        Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture.
        Hum Reprod. 2010; 25: 2256-2263
        • Croxatto H.B.
        • Brache V.
        • Pavez M.
        • et al.
        Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation.
        Contraception. 2004; 70: 442-450
        • Stratton P.
        • Levens E.
        • Hartog B.
        • et al.
        Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914.
        Fertil Steril. 2010; 93: 2035-2040
        • Glasier A.
        Emergency contraception: clinical outcomes.
        Contraception. 2013; 87: 309-313
        • Zinaman M.J.
        • Clegg E.D.
        • Brown C.C.
        • et al.
        Estimates of human fertility and pregnancy loss.
        Fertil Steril. 1996; 65: 503-509
      6. Ulipristal Acetate. [Package insert]. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022474s000lbl.pdf. Accessed May 8, 2015.

        • Levy D.
        • Jager M.
        • Kapp N.
        • et al.
        Ulipristal acetate for emergency contraception: postmarketing experience after use by more than 1 million women.
        Contraception. 2014; 89: 431-433
        • Orleans R.J.
        Clinical review. NDA22–474. Ella (ulipristal acetate 30 mg).
        US Food and Drug Administration, 2010 (Available at:) (Accessed September 7, 2015)
        • Saav I.
        • Fiala C.
        • Hamalainen J.M.
        • et al.
        Medical abortion in lactating women: low levels of mifepristone in breast milk.
        Acta Obstet Gynecol Scand. 2010; 89: 618-622
      7. Plan B Onestep. [Package insert]. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021998lbl.pdf. Accessed May 8, 2015.

        • von Hertzen H.
        • Piaggio G.
        • Ding J.
        • et al.
        Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicenter randomized trial.
        Lancet. 2002; 360: 1803-1810
      8. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation.
        Lancet. 1998; 352: 428-433
        • Arowojolu A.O.
        • Okewole I.A.
        • Adekunle A.O.
        Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians.
        Contraception. 2002; 66: 269-273
        • Ngai S.W.
        • Fan S.
        • Li S.
        • et al.
        A randomized trial to compare 24h versus 12h double dose regimen of levonorgestrel for emergency contraception.
        Hum Reprod. 2004; 20: 307-311
        • Ho P.C.
        • Kwan M.S.
        A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception.
        Hum Reprod. 1993; 8: 389-392
        • Wu S.
        • Wang C.
        • Wang Y.
        • et al.
        A randomized, double blind, multicenter study on comparing levonorgestrel and mifepristone for emergency contraception.
        J Reprod Med. 1999; 8: 43-46
        • Hamoda H.
        • Ashok P.W.
        • Stalder C.
        • et al.
        A randomized control trial of mifepristone (10 mg) and levonorgestrel for emergency contraception.
        Obstet Gynecol. 2004; 104: 1307-1313
        • Zhang L.
        • Chen J.
        • Wang Y.
        • et al.
        Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study.
        Hum Reprod. 2009; 24: 1605-1611
        • Sambol N.C.
        • Harper C.C.
        • Kim L.
        • et al.
        Pharmakokinetics of single dose levonorgestrel in adolescents.
        Contraception. 2006; 74: 104-109
        • Kook K.
        • Gabelnick H.
        • Duncan G.
        Pharmacokinetics of levonorgestrel 0.75 mg tablets.
        Contraception. 2002; 66: 73-76
        • Gainer E.
        • Massai R.
        • Lillo S.
        • et al.
        Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1.5 mg for emergency contraception.
        Hum Reprod. 2007; 22: 1578-1584
        • Batur P.
        Emergency contraception: separating fact from fiction.
        Cleve Clin J Med. 2012; 79: 771-776
      9. International Consortium for Emergency Contraception. Using oral birth control pills as EC. 2014. Available at: www.cecinof.org. Accessed March 27, 2015.

        • von Hertzen H.
        • Piaggio G.
        Emergency contraception with levonorgestrel or the Yuzpe regimen.
        Lancet. 1939; 1998: 352
        • Raman-Wilms L.
        • Tseng A.L.
        • Wighardt S.
        • et al.
        Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis.
        Obstet Gynecol. 1995; 85: 141-149
        • American College of Obsetricians and Gynecologists
        ACOG committee opinion no. 542: access to emergency contraception.
        Obstet Gynecol. 2012; 120: 1250-1253
        • Committee on Adolescence
        Emergency contraception.
        Pediatrics. 2005; 116: 1026
      10. Stream G. American Academy of Family Physicians Statement: AAFP Opposes U.S. Department of Justice’s Appeal of Emergency Contraception Ruling. [Press Release]. Available at: http://www.aafp.org/media-center/releases-statements/all/2013/contraception-planb.html. Accessed May 13, 2015.

      11. American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society of Adolescent Health and Medicine. Medical groups denounce HHS decision on access to emergency contraception: move defies strong evidence that emergency contraception is a safe, effective tool to prevent unintended pregnancy. [Press Release]. 2011. Available at: http://www.acog.org/∼/media/News%20Releases/20111207Release.ashx. Accessed May 13, 2015.

      12. Association of Reproductive Health Professionals. Available at: https://www.arhp.org/about-us/position-statements. Accessed May 13, 2015.

      13. American Public Health Association. Support of public education about emergency contraception and reduction or elimination of barriers to access. Policy Date: 11/18/2003 Policy Number: 200315. Available at: http://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2014/07/24/15/29/support-of-public-ed-about-emergency-contraception-and-elimination-of-barriers-to-access. Accessed May 13, 2015.

        • Mackin M.L.
        • Clark K.
        Emergency contraception in Iowa pharmacies before and after over-the-counter approval.
        Public Health Nurs. 2011; 28: 317-324
        • Bayer L.L.
        • Edelman A.
        • Caughey A.B.
        • et al.
        The price of emergency contraception in the United States: what is the cost-effectiveness of ulipristal acetate versus single-dose levonorgestrel?.
        Contraception. 2013; 87: 385-390
      14. Association of Reproductive Health Professionals (ARHP). 2011 Update on emergency contraception. Curricula Organizer for Reproductive Health Education (CORE). Available at: http://www.arhp.org/uploadDocs/CPECUpdate.pdf. Accessed May 13, 2015.

        • Brant A.
        • White K.
        • St. Marie P.
        Pharmacy availability of ulipristal acetate emergency contraception: an audit study.
        Contraception. 2014; 90: 338-339
        • Wilkinson T.A.
        • Vargas G.
        • Fahey N.
        • et al.
        “I'll see what I can do”: What adolescents experience when requesting emergency contraception.
        J Adolesc Health. 2014; 54: 14-19
      15. Thompson K, Belden P. Counseling for emergency contraception: time for a tiered approach. Available at: www.arhp.org. Accessed April 12, 2015.

        • Schwarz E.
        • Kavanaugh M.
        • Douglas E.
        • et al.
        Interest in intrauterine contraception among seekers of emergency contraception and pregnancy testing.
        Obstet Gynecol. 2009; 113: 833-839
        • Patel A.
        • Roston A.
        • Tilmon S.
        • et al.
        Assessing the extent of provision of comprehensive medical care management for female sexual assault patients in US hospital emergency departments.
        Int J Gynaecol Obstet. 2013; 123: 24-28
        • Holmes M.M.
        • Resnick H.S.
        • Kilpatrick G.G.
        • et al.
        Rape-related pregnancy: estimates and descriptive characteristics from a national sample of women.
        Am J Obstet Gynecol. 1996; 175: 320-325
        • Patel A.
        • Tilmon S.
        • Bhogireddy V.
        • et al.
        Emergency contraception after sexual assault: changes in provision from 2004-2009.
        J Reprod Med. 2012; 57: 98-104
        • Bakhru A.
        • Mallinger J.B.
        • Fox M.C.
        Postexposure prophylaxis for victims of sexual assault: treatments and attitudes of emergency department physicians.
        Contraception. 2010; 82: 168-173